Leukocyte interleukin(CEL-SCI)

N/A

Report date: 2026/05/15 20:01:45

Base Information

Drug NameLeukocyte interleukin(CEL-SCI)
Drug Alias NameInterleukin-2 cocktail(CEL-SCI)Buffy coat interleukins(CEL-SCI)MultikineBC-IL
ClassificationBiologics > Blood components
Mechanisms of ActionImmunostimulantsT lymphocytes stimulantsNatural killer cells stimulants
TargetsNot applicable
Therapy Area/IndicationsOral Squamous Cell CarcinomaProstatic NeoplasmsUterine Cervical Neoplasms +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBosnia and HerzegovinaCanadaUnited States +[23] 
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesCel-Sci
China Registration ClassN/A

Develop Information

Active CompaniesCel-Sci CorporationNaval Medical Research CenterOrient Europharma Co Ltd +[5] 
Inactive CompaniesN/A
Active IndicationsProstatic NeoplasmsUterine Cervical NeoplasmsBreast Neoplasms +[5] 
Inactive IndicationsOral Squamous Cell CarcinomaHead and Neck NeoplasmsCondylomata Acuminata

Other Information

ATC CodeN/A
Related LinksDrugBank